Alfresa Holdings: Change Report (Stock Certificates Eligible for Special Provisions, etc.)
Alfresa Holdings: Notice regarding completion of share acquisition of the newly established split company of INTAGE HEALTHCARE CO., LTD.
Alfresa Holdings: About the construction of a vaccine supply optimization platform using Salesforce products by Alfresa Corporation
Alfresa Holdings: Notice Concerning Organizational Reforms, Executive Changes, and Personnel Changes at Subsidiaries
Alfresa Holdings: Overview of Q1 2025 earnings report.
Alfresa Holdings: First Quarter Financial Results Short Message (Consolidated) for March 2025 [Japanese Standards]
Alfresa Holdings: Alphressa Corporation and Apocrit Corporation are participating in the trial operation of the ReMed recycling project for disposable syringes that contribute to reducing plastic waste.
Alfresa Holdings: Announcements of individual stocks regarding organizational reform at subsidiary companies.
Alfresa Holdings: Announcements of individual stocks regarding organizational reform and personnel changes in the subsidiary.
Alfresa Holdings: Interim report
Alfresa Holdings: Announcements of individual stocks regarding the transfer of company executives in subsidiary.
Alfresa Holdings: Corporate Governance Report
Alfresa Holdings: Corporate Governance Report June 26, 2024
Alfresa Holdings: Internal Control Report - 21st Term (2023/04/01 - 2024/03/31)
Alfresa Holdings: Securities Report - 21st term (April 1, 2023 - March 31, 2024)
Alfresa Holdings: Confirmation letter
Alfresa Holdings: Regarding the acquisition of shares (subsidiarization) of the newly established split company of Integ Healthcare Co., Ltd.
Alfresa Holdings: Regarding the capital partnership with Morikubo CA Medical Co., Ltd.
Alfresa Holdings: Alphressa Corporation has signed a basic agreement for business partnership with Helios Corporation and will underwrite the issuance of corporate bonds by Helios Corporation.
Alfresa Holdings: Independent Officer Notification Form
No Data
No Data